Total Payments
$176,642
2024 Payments
$6,859
Companies
68
Transactions
1,257
Medicare Patients
3,788
Medicare Billing
$1.0M
Payment Breakdown by Category
Other$144,963 (82.1%)
Food & Beverage$25,289 (14.3%)
Travel$5,588 (3.2%)
Education$503.25 (0.3%)
Consulting$300.00 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $144,963 | 78 | 82.1% |
| Food and Beverage | $25,289 | 1,135 | 14.3% |
| Travel and Lodging | $5,588 | 33 | 3.2% |
| Education | $503.25 | 9 | 0.3% |
| Consulting Fee | $300.00 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $54,195 | 168 | $0 (2024) |
| Amgen Inc. | $36,201 | 112 | $0 (2024) |
| Allergan, Inc. | $29,948 | 79 | $0 (2022) |
| Supernus Pharmaceuticals, Inc. | $23,485 | 72 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $11,933 | 21 | $0 (2021) |
| Biohaven Pharmaceutical Holding Company Ltd. | $2,772 | 12 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $2,164 | 84 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $1,493 | 117 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $1,422 | 34 | $0 (2024) |
| Biogen, Inc. | $1,244 | 60 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,859 | 163 | ABBVIE INC. ($3,354) |
| 2023 | $7,022 | 177 | ABBVIE INC. ($3,936) |
| 2022 | $52,342 | 212 | ABBVIE INC. ($40,735) |
| 2021 | $30,988 | 174 | Biohaven Pharmaceuticals, Inc. ($11,933) |
| 2020 | $40,536 | 114 | Allergan, Inc. ($27,531) |
| 2019 | $11,414 | 177 | Amgen Inc. ($9,158) |
| 2018 | $25,087 | 135 | Supernus Pharmaceuticals, Inc. ($22,776) |
| 2017 | $2,393 | 105 | Sunovion Pharmaceuticals Inc. ($1,217) |
All Payment Transactions
1,257 individual payment records from CMS Open Payments — Page 1 of 51
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Neurology | ||||||
| 12/19/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: EPILEPSY | ||||||
| 12/17/2024 | ABBVIE INC. | QULIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/16/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $31.92 | General |
| Category: Neurology | ||||||
| 12/11/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/10/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $27.08 | General |
| Category: Immunology | ||||||
| 11/27/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: NEUROSCIENCE | ||||||
| 11/25/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Immunology | ||||||
| 11/25/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: PAIN | ||||||
| 11/14/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: Neuroscience | ||||||
| 11/13/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Neurology | ||||||
| 11/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/07/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $13.10 | General |
| Category: Narcoplepsy | ||||||
| 11/06/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: Neurology | ||||||
| 11/04/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $31.92 | General |
| Category: Neurology | ||||||
| 11/04/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Neurology | ||||||
| 10/28/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/23/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 10/22/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $108.32 | General |
| Category: Neuroscience | ||||||
| 10/16/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: Neuroscience | ||||||
| 10/14/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: Neurology | ||||||
| 10/14/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 878 | 31,521 | $568,234 | $229,798 |
| 2022 | 15 | 935 | 39,835 | $736,735 | $276,854 |
| 2021 | 13 | 884 | 35,141 | $672,460 | $254,973 |
| 2020 | 19 | 1,091 | 36,034 | $723,050 | $253,776 |
Total Patients
3,788
Total Services
142,531
Medicare Billing
$1.0M
Procedure Codes
70
All Medicare Procedures & Services
70 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 46 | 30,400 | $364,800 | $144,848 | 39.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 235 | 330 | $39,930 | $19,337 | 48.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 139 | 202 | $30,906 | $16,172 | 52.3% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 34 | 124 | $37,800 | $13,785 | 36.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 53 | 53 | $14,840 | $7,533 | 50.8% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 86 | 86 | $25,238 | $7,341 | 29.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 33 | 33 | $7,128 | $4,062 | 57.0% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 40 | 40 | $13,021 | $3,333 | 25.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $5,460 | $3,074 | 56.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 29 | 47 | $9,400 | $3,014 | 32.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 43 | 66 | $3,084 | $2,083 | 67.5% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2023 | 15 | 15 | $2,331 | $1,168 | 50.1% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 13 | 13 | $3,900 | $1,073 | 27.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 11 | 11 | $3,758 | $1,064 | 28.3% |
| 95909 | Nerve conduction, 5-6 studies | Facility | 2023 | 13 | 13 | $1,244 | $699.84 | 56.2% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Facility | 2023 | 17 | 17 | $1,894 | $539.36 | 28.5% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2023 | 13 | 13 | $2,860 | $401.76 | 14.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 32 | 32 | $640.00 | $268.80 | 42.0% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 56 | 38,600 | $463,200 | $182,580 | 39.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 271 | 392 | $47,432 | $22,315 | 47.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 150 | 233 | $35,649 | $19,304 | 54.2% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 46 | 154 | $92,400 | $17,370 | 18.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 56 | 56 | $11,760 | $6,744 | 57.4% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2022 | 70 | 70 | $25,984 | $6,209 | 23.9% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2022 | 64 | 64 | $23,280 | $5,655 | 24.3% |
About Dr. Robert Gardner, MD
Dr. Robert Gardner, MD is a Clinical Neurophysiology healthcare provider based in Cape Girardeau, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1649365917.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Gardner, MD has received a total of $176,642 in payments from pharmaceutical and medical device companies, with $6,859 received in 2024. These payments were reported across 1,257 transactions from 68 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($144,963).
As a Medicare-enrolled provider, Gardner has provided services to 3,788 Medicare beneficiaries, totaling 142,531 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 70 distinct procedure/service records.
Ad
Practice Information
- Specialty Clinical Neurophysiology
- Other Specialties Neurology
- Location Cape Girardeau, MO
- Active Since 10/04/2006
- Last Updated 06/26/2024
- Taxonomy Code 2084N0600X
- Entity Type Individual
- NPI Number 1649365917
Products in Payments
- UBRELVY (Drug) $64,004
- Aimovig (Biological) $35,970
- TROKENDI XR (Drug) $23,266
- QULIPTA (Drug) $18,900
- NURTEC ODT (Drug) $14,916
- APTIOM (Drug) $2,182
- EPIDIOLEX (Drug) $1,124
- Epidiolex (Drug) $840.46
- KESIMPTA (Drug) $795.36
- WAKIX (Drug) $554.16
- OCREVUS (Biological) $544.29
- TYSABRI (Biological) $448.62
- BOTOX (Biological) $434.22
- ZEPOSIA (Drug) $418.83
- Briviact (Drug) $408.27
- Leqembi (Drug) $370.65
- AUBAGIO (Drug) $363.52
- Ponvory (Drug) $358.77
- MAYZENT (Drug) $347.72
- VUMERITY (Drug) $317.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.